Alan Burghauser
Pulmonary Disease · Union, NJNPI 1992806608
Payments from drug & device makers
Across 445 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Actelion Pharmaceuticals US, Inc.$907
- AstraZeneca$865
- Sunovion Pharmaceuticals Inc.$615
- Philips North America LLC$484
- Boehringer Ingelheim$330
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,41599%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 105 | $1,257 |
| Actelion Pharmaceuticals US, Inc. | 60 | $907 |
| AstraZeneca | 29 | $865 |
| Sunovion Pharmaceuticals Inc. | 54 | $615 |
| Philips North America LLC | 26 | $484 |
| Boehringer Ingelheim | 26 | $330 |
| Bayer | 16 | $252 |
| Regeneron Healthcare Solutions, Inc. | 15 | $194 |
| Sanofi | 13 | $176 |
| United Therapeutics Corporation | 11 | $142 |
| Mallinckrodt Hospital Products Inc. | 10 | $138 |
| Mylan Specialty L.p. | 10 | $137 |
| Covis Pharma GmbH | 9 | $130 |
| Advanced Respiratory, Inc | 7 | $130 |
| Insmed, Inc. | 9 | $122 |
| Jazz Pharmaceuticals Inc. | 8 | $109 |
| Pfizer | 6 | $87 |
| ANI Pharmaceuticals, Inc. | 5 | $67 |
| Mallinckrodt Enterprises LLC | 4 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Gilead | 2 | $33 |
| Electromed, Inc. | 2 | $32 |
| Optinose US, Inc. | 2 | $27 |
| Resmed Corp | 1 | $26 |
| Grifols USA, LLC | 2 | $26 |
| Harmony Biosciences LLC | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Circassia Inc. | 1 | $13 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| Boston Scientific | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,502 in reported general payments places this provider in the 70th percentile of 472 pulmonary disease providers in New Jersey.
Other pulmonary disease in Union
- Ilia SegalUnion$18K
- Reynold PanettieriNew Brunswick$2.5M
- Vinay SikandToms River$1.8M
- Stanley FielMorristown$1.3M
- Joseph HoffmanPark Ridge$1.1M
- Robert SussmanSummit$645K
- Ronaldo GoHackensack$563K
- Deborah GossHackensack$558K
- Sabina HussainNew Brunswick$555K
- Manuel CunananMillville$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.